Q32 Bio
QTTB
QTTB
102 hedge funds and large institutions have $574M invested in Q32 Bio in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $582M → $574M (-$7.95M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
82% less call options, than puts
Call options by funds: $250K | Put options by funds: $1.4M
Holders
102
Holding in Top 10
2
Calls
$250K
Puts
$1.4M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$10M | |
| 3 | +$9.75M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$7.09M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.3M |
Top Sellers
| 1 | -$62.7M | |
| 2 | -$8.76M | |
| 3 | -$5.24M | |
| 4 |
GTP
Global Thematic Partners
New York
|
-$3.4M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.02M |